148146-51-4,
Atorvastatin Epoxydione Impurity,
A1-01742,
A1-01743,
3-((4-Fluorophenyl)carbonyl)-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2-carboxamide,
3-[(4-Fluorophenyl)carbonyl]-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2-carboxamide,
Atorvastatin calcium trihydrate impurity D [EP],
Atorvastatin EP Impurity E,
SCHEMBL2546242,
Atorvastatin USP Related Compound D,
ACN-048510,
Oxiranecarboxamide, 3-(4-fluorobenzoyl)-2-(2-methyl-1-oxopropyl)-N,3-diphenyl-,
ACM148146514,
FT-0662331,
3-(4-Fluorobenzoyl)-2-isobutyryl-N,3-diphenyloxirane-2-carboxamide,
2-Oxiranecarboxamide, 3-(4-fluorobenzoyl)-2-(2-methyl-1-oxopropyl)-N,3-diphenyl-,
3-(4-Fluorobenzoyl)-2-(2-methyl-1-oxopropyl)-N,3-diphenyloxiranecarboxamide,
3-(4-fluorobenzoyl)-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2-carboxamide,
Impurity D,
UNII-TP7T4AJ7RD,
TP7T4AJ7RD,
Atorvastatin EP Impurity D,
CID11976726,
501121-34-2,
3-(4-fluorobenzoyl)-2-(2-methylpropanoyl)-N,3-diphenyl-oxirane-2-carboxamide,